These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 212568)
1. Genetic analyses of differences in incidence of mammary tumors and reticulum cell neoplasms with the use of recombinant inbred lines of mice. Dux A; Mühlbock O; Bailey DW J Natl Cancer Inst; 1978 Oct; 61(4):1125-9. PubMed ID: 212568 [TBL] [Abstract][Full Text] [Related]
3. T cell subsets involved in lethal graft-versus-host disease directed to immunodominant minor histocompatibility antigens. Berger M; Wettstein PJ; Korngold R Transplantation; 1994 Apr; 57(7):1095-102. PubMed ID: 7909395 [TBL] [Abstract][Full Text] [Related]
4. The effect of the Cmv-1 resistance gene, which is linked to the natural killer cell gene complex, is mediated by natural killer cells. Scalzo AA; Fitzgerald NA; Wallace CR; Gibbons AE; Smart YC; Burton RC; Shellam GR J Immunol; 1992 Jul; 149(2):581-9. PubMed ID: 1378069 [TBL] [Abstract][Full Text] [Related]
5. Loss of heterozygosity occurs via mitotic recombination in Trp53+/- mice and associates with mammary tumor susceptibility of the BALB/c strain. Blackburn AC; McLary SC; Naeem R; Luszcz J; Stockton DW; Donehower LA; Mohammed M; Mailhes JB; Soferr T; Naber SP; Otis CN; Jerry DJ Cancer Res; 2004 Aug; 64(15):5140-7. PubMed ID: 15289317 [TBL] [Abstract][Full Text] [Related]
6. Autogenous antibodies against the murine mammary tumor virus in strains of mice with low incidences of mammary tumors. Michalides R; Wagenaar E; Nusse R J Natl Cancer Inst; 1979 Apr; 62(4):935-41. PubMed ID: 219283 [TBL] [Abstract][Full Text] [Related]
7. Kinetics of responses to tumor antigens and mouse mammary tumor virus in BALB/cCrgl and BALB/cfC3H mice. Lopez DM; Sigel MM; Charyulu VL J Natl Cancer Inst; 1981 Jan; 66(1):191-6. PubMed ID: 6256573 [TBL] [Abstract][Full Text] [Related]
8. Immunodominance in the graft-vs-host disease T cell response to minor histocompatibility antigens. Korngold R; Wettstein PJ J Immunol; 1990 Dec; 145(12):4079-88. PubMed ID: 2258608 [TBL] [Abstract][Full Text] [Related]
9. Comparative studies of purified subviral component vaccines and formalin-treated mammary tumor viruses from four inbred strains of mice. Girardi AJ; Dion AS; Pomenti AA; Holben JA J Natl Cancer Inst; 1985 Feb; 74(2):405-13. PubMed ID: 2983136 [TBL] [Abstract][Full Text] [Related]
10. Induction of endogenous mammary tumor virus expression during hormonal induction of mammary adenoacanthomas and carcinomas of BALB/c female mice. McGrath CM; Prass WA; Maloney TM; Jones RF J Natl Cancer Inst; 1981 Oct; 67(4):841-52. PubMed ID: 6268884 [TBL] [Abstract][Full Text] [Related]
11. Multiple genetic factors in the MHC and predominant role of D-end in the resistance against C3H-MTV-induced mammary tumors. Dux A Transplant Proc; 1983 Dec; 15(4):2101-3. PubMed ID: 6324428 [No Abstract] [Full Text] [Related]
12. Impact of ionizing radiation and genetic background on mammary tumorigenesis in p53-deficient mice. Backlund MG; Trasti SL; Backlund DC; Cressman VL; Godfrey V; Koller BH Cancer Res; 2001 Sep; 61(17):6577-82. PubMed ID: 11522657 [TBL] [Abstract][Full Text] [Related]
13. A new locus (Mtv-4) for endogenous mammary tumor virus expression and early mammary tumor development in the SHN mouse strain. Imai S; Tsubura Y; Hilgers J; Michalides R J Natl Cancer Inst; 1983 Sep; 71(3):517-21. PubMed ID: 6310199 [TBL] [Abstract][Full Text] [Related]
14. Immunodominant CD4+ T cell receptor Vbeta repertoires involved in graft-versus-host disease responses to minor histocompatibility antigens. Berger MA; Korngold R J Immunol; 1997 Jul; 159(1):77-85. PubMed ID: 9200441 [TBL] [Abstract][Full Text] [Related]
15. Immunologic studies with mouse mammary tumor viruses: comparative studies with spontaneous mammary tumor cell vaccines from five inbred mouse strains. Girardi AJ; Dion AS; Holben JA J Natl Cancer Inst; 1985 Jan; 74(1):105-12. PubMed ID: 2982052 [TBL] [Abstract][Full Text] [Related]
16. Alterations of acquired mouse mammary tumor virus DNA during mammary tumorigenesis in BALB/cfC3H mice. Cardiff RD; Morris DW; Young LJ J Natl Cancer Inst; 1983 Nov; 71(5):1011-9. PubMed ID: 6316008 [TBL] [Abstract][Full Text] [Related]
17. Expression of mammary tumor virus proteins in preneoplastic outgrowth lines and mammary tumors of BALB/cV mice. Slagle BL; Lanford RE; Medina D; Butel JS Cancer Res; 1984 May; 44(5):2155-62. PubMed ID: 6324998 [TBL] [Abstract][Full Text] [Related]
18. Mouse strain (STS/A) resistant to mammary tumor induction by hypophysial isografts. van der Gugten AA; Röpcke G; van Nie R; Hilgers J Cancer Res; 1985 Aug; 45(8):3448-53. PubMed ID: 4016729 [TBL] [Abstract][Full Text] [Related]
19. Reevaluation of the effect of mouse mammary tumor virus infection on the BALB/c mouse hyperplastic outgrowth. Ashley RL; Cardiff RD; Fanning TG J Natl Cancer Inst; 1980 Nov; 65(5):977-86. PubMed ID: 6253710 [TBL] [Abstract][Full Text] [Related]
20. Variations in genetic control of susceptibility to Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease. I. Differences between susceptible SJL/J and resistant BALB/c strains map near the T cell beta-chain constant gene on chromosome 6. Melvold RW; Jokinen DM; Knobler RL; Lipton HL J Immunol; 1987 Mar; 138(5):1429-33. PubMed ID: 3027179 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]